London (ots/PRNewswire) - Raltitrexed (Tomudex(R)) in combination with cisplatin in the treatment of MPM improves median overall survival compared to treatment with cisplatin alone.[1] With incidence rates expected to double over the next 20 years in many countries[2], new and effective treatments are a welcome addition, concluded an eminent panel of international ...
London, February 22, 2010 (ots/PRNewswire) - Hospira announced today that the European Committee for Medicinal Products for Human Use (CHMP) has recommended for approval the administration of Retacrit (epoetin zeta) subcutaneously in the nephrology setting. This provides an alternative option to intravenous (IV) ...
Amsterdam, Netherlands (ots/PRNewswire) - - Hospira Healthcare B.V. will also serve as regional headquarters for Europe, Middle East and Africa -- Today Hospira, Inc. (pronounced Hos-PEER-ah), a global independent specialty pharmaceutical and medication delivery company created in April 2004 from the core global hospital products business of Abbott Laboratories, announced that it has established its presence ...